< Back to latest news & events

UPC

Provisional Phase of the UPC can now begin

January 2022

With the deposit on 18 January 2022 by Austria of its instrument of ratification for the Protocol on Provisional Application Period (PAP- Protocol; see here), the UPC’s Provisional Phase can now begin. The Provisional Phase allows for the finalisation of secondary legislation and Rules of Procedure, the Court filing system and IT infrastructure, financial budgets, and most importantly, the hiring of the UPC’s staff, including the appointment of judges.

The Provisional Phase is expected to last eight to ten months and it is hoped it will conclude in Q3 / Q4 2022.  Once the UPC Preparatory Committee are satisfied that the UPC infrastructure is in place, Germany will deposit its ratification of the UPC Agreement thereby starting the 4 month countdown to the official start of the UPC.

Within that countdown, we expect there to be a three-month sunrise period when patentees can file “opt-outs” for existing EPs, as well as indicating that they wish to designate a Unitary Patent for EPs proceeding to grant.

It is important that patentees give sufficient time to adjust their patenting strategies and review their EP portfolios to ensure these are aligned to business needs ahead of the launch of the UPC.

See our UPC news section for more information or email upcready@hgf.com with any questions.

Latest updates

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Read article

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Read article
Event - 5th November 2025

HGF are Gold Sponsors of IAM Live: Navigating the UPC 2025

We’re excited to share that HGF is a Gold Sponsor of IAM Live: Navigating the UPC 2025, taking place on the 5th November at the Marriott Opera Ambassador Hotel in …

Event details

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article